ADVANCED BILIARY TRACT CANCER
Clinical trials for ADVANCED BILIARY TRACT CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED BILIARY TRACT CANCER trials appear
Sign up with your email to follow new studies for ADVANCED BILIARY TRACT CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for tough bile duct cancer
Disease control OngoingThis study tests a combination of two drugs, lenvatinib and paclitaxel, in people with advanced bile duct cancer that has stopped responding to standard chemotherapy. The goal is to see if this treatment can shrink tumors or slow the disease. About 51 adults with various types of…
Matched conditions: ADVANCED BILIARY TRACT CANCER
Phase: PHASE2 • Sponsor: National Health Research Institutes, Taiwan • Aim: Disease control
Last updated May 17, 2026 05:36 UTC
-
Immunotherapy duo takes on rare cancers: hope for patients with few options
Disease control OngoingThis study tests a combination of two immunotherapy drugs, ipilimumab and nivolumab, in people with rare cancers that are known to respond to immunotherapy. The cancers include certain neuroendocrine tumors, biliary tract cancers, gynecological cancers, and mismatch repair defici…
Matched conditions: ADVANCED BILIARY TRACT CANCER
Phase: PHASE2 • Sponsor: Olivia Newton-John Cancer Research Institute • Aim: Disease control
Last updated May 17, 2026 05:36 UTC
-
New hope for bile duct cancer: drug combo shows promise in halting tumor growth
Disease control OngoingThis study tests a combination of three drugs (fluorouracil, leucovorin, and nanoliposomal irinotecan) in 48 adults with advanced bile duct or gallbladder cancer that has worsened after standard chemotherapy. The main goal is to see if the treatment can stop the cancer from growi…
Matched conditions: ADVANCED BILIARY TRACT CANCER
Phase: PHASE2 • Sponsor: Georgetown University • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New drug duo shows promise for tough bile duct cancer
Disease control OngoingThis study tests whether combining two drugs, regorafenib and durvalumab, can help people with advanced bile duct cancer that has stopped responding to chemotherapy. About 40 participants will receive the combination to see if it slows tumor growth and how safe it is. The goal is…
Matched conditions: ADVANCED BILIARY TRACT CANCER
Phase: PHASE1, PHASE2 • Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated May 11, 2026 20:38 UTC